Infarmed has ordered the suspension of marketing and withdrawal from the market of two creams containing cannabidiol, the use of which is prohibited in cosmetic.
Close to 26 tons of cannabis cultivated and produced in Portugal have been exported since 2019, the year in which the use of this plant for medicinal purposes.
Infarmed has warned of constraints in the supply of medicines for the treatment of hyperactivity disorder and attention deficit disorder, calling on healthcare.
The use of the drug pembrolizumab in metastatic triple-negative breast cancer, claimed by patients, will be authorised by Infarmed, according to an official.